CD8A and posterior cortical atrophy: Consistent with our study, the high-risk group in this model had a lower abundance of CD8+ T-cells and a higher abundance of M2-type TAMs, suggesting that this BMRM provides clues to the study of immunotherapy and has implications for immunotherapy decisions in PCa patients.